Abstract
Pancreatic ductal adenocarcinoma remains a major challenge in cancer medicine. Given the increase in incidence and mortality, interdisciplinary research is necessary to translate basic knowledge into therapeutic strategies improving the outcome of patients. On the 4th and 5th of February 2021, three German pancreatic cancer research centers, the Clinical Research Unit 5002 from Göttingen, the Collaborative Research Center 1321 from Munich, and Clinical Research Unit 325 from Marburg organized the 1st Virtual Göttingen-Munich-Marburg Pancreatic Cancer Meeting in order to foster scientific exchange. This report summarizes current research and proceedings presented during that meeting.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 785-791 |
| Number of pages | 7 |
| Journal | Gastroenterology |
| Volume | 161 |
| Issue number | 3 |
| DOIs | |
| State | Published - Sep 2021 |
Keywords
- Emerging Therapies
- Genome Dynamics
- Microenvironment
- Molecular Subtypes
- Pancreatic Cancer
ASJC Scopus subject areas
- Hepatology
- Gastroenterology
Access to Document
Other files and links
Fingerprint
Dive into the research topics of 'New Insights Into Pancreatic Cancer: Notes from a Virtual Meeting'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS
In: Gastroenterology, Vol. 161, No. 3, 09.2021, p. 785-791.
Research output: Contribution to journal › Article › peer-review
}
TY - JOUR
T1 - New Insights Into Pancreatic Cancer
T2 - Notes from a Virtual Meeting
AU - 1 Virtual Göttingen-Munich-Marburg Pancreatic Cancer Meeting
AU - Hessmann, Elisabeth
AU - Schneider, Günter
AU - Bousquet, Corinne
AU - Der, Channing
AU - Dreyer, Stephan
AU - Dusetti, Nelson
AU - Eilers, Martin
AU - Ellenrieder, Volker
AU - Espinet, Elisa
AU - Falcomatà, Chiara
AU - Feldmann, Karin
AU - Gebhardt, Anneli
AU - Gress, Thomas
AU - Hamdan, Feda
AU - Huber, Magdalena
AU - Johnsen, Steven A.
AU - Kleger, Alexander
AU - Krenz, Bastian
AU - Lomberk, Gwen
AU - Mazur, Pawel
AU - Michl, Patrick
AU - Morton, Jennifer
AU - Pasca di Magliano, Marina
AU - Picard, Felix
AU - Reichert, Maximilian
AU - Saur, Dieter
AU - Schmid, Roland
AU - Sebens, Susanne
AU - Singh, Shiv K.
AU - Siveke, Jens
AU - Trumpp, Andreas
N1 - Funding Information: Funding The work was supported by Deutsche Forschungsgemeinschaft: CRU/KFO5002, CRC/SFB1321 (Project-ID 329628492), and CRU/KFO325. Funding Information: The authors thank Anirban Maitra for help, advice, and discussion of the meeting report, as well as Alexander M?ller for organizing the meeting. The authors thank the Deutsche Pankreas Club for announcing and supporting the meeting. Contributors of the 1st Virtual G?ttingen-Munich-Marburg Pancreatic Cancer Meeting: Corinne Bousquet (INSERM UMR-1037, Cancer Research Center of Toulouse, Team Labellis?e Ligue Contre le Cancer, Laboratoire d'Excellence Toulouse Cancer, Toulouse, France), Channing Der (Department of Pharmacology, Curriculum in Genetics and Molecular Biology, Lineberger Comprehensive Cancer Center, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina and Charit? Universit?tsmedizin Berlin, Institute of Pathology, Laboratory of Molecular Tumor Pathology and Systems Biology, Berlin, Germany), Stephan Dreyer (Wolfson Wohl Cancer Research Centre, Institute of Cancer Sciences, University of Glasgow, Glasgow, Scotland, UK; West of Scotland Pancreatic Unit, Glasgow Royal Infirmary, Glasgow, United Kingdom), Nelson Dusetti (Cancer Research Center of Marseille, (CRCM), INSERM U1068, CNRS UMR 7258, Paoli-Calmettes Institut, Aix-Marseille University, Parc Scientifique et Technologique de Luminy, Marseille, France), Martin Eilers (Theodor Boveri Institute, Department of Biochemistry and Molecular Biology, Biocenter, University of W?rzburg, W?rzburg, Germany), Volker Ellenrieder (Department of Gastroenterology, Gastrointestinal Oncology and Endocrinology, University Medical Center G?ttingen, G?ttingen, Germany), Elisa Espinet (Heidelberg Institute for Stem Cell Technology and Experimental Medicine GmbH, Heidelberg, Germany; and Department of Stem Cells and Cancer, German Cancer Research Center, Heidelberg, Germany), Chiara Falcomat? (Division of Translational Cancer Research, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany; Chair of Translational Cancer Research and Institute for Experimental Cancer Therapy, Klinikum rechts der Isar, School of Medicine, Technische Universit?t M?nchen, M?nchen, Germany; Center for Translational Cancer Research (TranslaTUM), School of Medicine, Technical University of Munich, Munich, Germany), Karin Feldmann (Medical Clinic and Policlinic II, Klinikum rechts der Isar, Technical University Munich, Munich, Germany), Anneli Gebhardt (Theodor Boveri Institute, Department of Biochemistry and Molecular Biology, Biocenter, University of W?rzburg, W?rzburg, Germany), Thomas Gress (Department of Gastroenterology, Endocrinology, Metabolism and Infectiology, Center for Tumor and Immunology, Philipps University Marburg, Marburg, Germany), Feda Hamdan (Gene Regulatory Mechanisms and Molecular Epigenetics Lab, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota), Magdalena Huber (Institute for Medical Microbiology and Hospital Hygiene, Philipps University Marburg, Marburg, Germany), Steven A. Johnsen (Gene Regulatory Mechanisms and Molecular Epigenetics Lab, Division of Gastroenterology and Hepatology, Mayo Clinic, Rochester, Minnesota), Alexander Kleger (Department of Internal Medicine 1, Ulm University Hospital, Ulm, Germany), Bastian Krenz (Theodor Boveri Institute, Department of Biochemistry and Molecular Biology, Biocenter, University of W?rzburg, W?rzburg, Germany), Gwen Lomberk (Departments of Surgery and Pharmacology and Toxicology, LaBahn Pancreatic Cancer Program, and Genomic Sciences and Precision Medicine Center, Medical College of Wisconsin, Milwaukee, Wisconsin), Pawel Mazur (Department of Experimental Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas), Patrick Michl (Martin-Luther-Universit?t Halle/Wittenberg, Klinik und Poliklinik f?r Innere Medizin I, Halle/Saale, Germany), Jennifer Morton (CRUK Beatson Institute and Institute of Cancer Sciences, University of Glasgow, Glasgow, UK), Marina Pasca di Magliano (Rogel Cancer Center and Department of Cell and Developmental Biology, University of Michigan, Ann Arbor, Michigan), Felix Picard (Institute for Medical Microbiology and Hospital Hygiene, Philipps University Marburg, Marburg, Germany), Maximilian Reichert (Medical Clinic and Policlinic II, Klinikum rechts der Isar, Technical University Munich, Munich, Germany), Dieter Saur (Division of Translational Cancer Research, German Cancer Research Center (DKFZ) and German Cancer Consortium (DKTK), Heidelberg, Germany; Chair of Translational Cancer Research and Institute for Experimental Cancer Therapy, Klinikum rechts der Isar, School of Medicine, Technische Universit?t M?nchen, M?nchen, Germany; Center for Translational Cancer Research (TranslaTUM), School of Medicine, Technical University of Munich, Munich, Germany), Roland Schmid (Medical Clinic and Policlinic II, Klinikum rechts der Isar, Technical University Munich, Munich, Germany), Susanne Sebens (Institute for Experimental Cancer Research, Kiel University and University Medical Center Schleswig-Holstein, Kiel, Germany), Shiv K. Singh (Department of Gastroenterology, Gastrointestinal Oncology and Endocrinology, University Medical Center G?ttingen, G?ttingen, Germany), Jens Siveke (Bridge Institute of Experimental Tumor Therapy, West German Cancer Center, University Medicine Essen, Essen, Germany; Division of Solid Tumor Translational Oncology, German Cancer Research Center and German Cancer Consortium, partner site Essen, Heidelberg, Germany), and Andreas Trumpp (Heidelberg Institute for Stem Cell Technology and Experimental Medicine GmbH, Heidelberg, Germany; and Department of Stem Cells and Cancer, German Cancer Research Center). Funding The work was supported by Deutsche Forschungsgemeinschaft: CRU/KFO5002, CRC/SFB1321 (Project-ID 329628492), and CRU/KFO325. Publisher Copyright: © 2021 The Authors
PY - 2021/9
Y1 - 2021/9
N2 - Pancreatic ductal adenocarcinoma remains a major challenge in cancer medicine. Given the increase in incidence and mortality, interdisciplinary research is necessary to translate basic knowledge into therapeutic strategies improving the outcome of patients. On the 4th and 5th of February 2021, three German pancreatic cancer research centers, the Clinical Research Unit 5002 from Göttingen, the Collaborative Research Center 1321 from Munich, and Clinical Research Unit 325 from Marburg organized the 1st Virtual Göttingen-Munich-Marburg Pancreatic Cancer Meeting in order to foster scientific exchange. This report summarizes current research and proceedings presented during that meeting.
AB - Pancreatic ductal adenocarcinoma remains a major challenge in cancer medicine. Given the increase in incidence and mortality, interdisciplinary research is necessary to translate basic knowledge into therapeutic strategies improving the outcome of patients. On the 4th and 5th of February 2021, three German pancreatic cancer research centers, the Clinical Research Unit 5002 from Göttingen, the Collaborative Research Center 1321 from Munich, and Clinical Research Unit 325 from Marburg organized the 1st Virtual Göttingen-Munich-Marburg Pancreatic Cancer Meeting in order to foster scientific exchange. This report summarizes current research and proceedings presented during that meeting.
KW - Emerging Therapies
KW - Genome Dynamics
KW - Microenvironment
KW - Molecular Subtypes
KW - Pancreatic Cancer
UR - http://www.scopus.com/inward/record.url?scp=85112794735&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85112794735&partnerID=8YFLogxK
U2 - 10.1053/j.gastro.2021.04.082
DO - 10.1053/j.gastro.2021.04.082
M3 - Article
C2 - 34089734
AN - SCOPUS:85112794735
SN - 0016-5085
VL - 161
SP - 785
EP - 791
JO - Gastroenterology
JF - Gastroenterology
IS - 3
ER -